Effectiveness of Knowledge by Video and Handbook of Liver Cancer Patients With First Trans-arterial Chemoembolization
NCT02768428 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2016-05-11
Summary
Objective: To compare the effectiveness between Video and Handbook on providing knowledge of TACE.
Study Design: A prospective, randomized, controlled trial.
Conditions
Interventions
- OTHER
-
Video-Audio Media
each arm spends 15 mins for watching the video or study the handbooks
Sponsors & Collaborators
-
Chulabhorn Hospital
lead OTHER
Principal Investigators
-
Ruechuta Molek, MNS · Chulabhorn Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2017-10-31
- Completion
- 2017-10-31
Countries
- Thailand
More Related Trials
-
Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma
NCT02109146 ·Status: COMPLETED ·Phase: PHASE3
-
Adjuvant Radiotherapy Comparing TACE for Curative HCC
NCT02125396 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance
NCT00926536 ·Status: COMPLETED ·Phase: NA
-
Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma
NCT01327521 ·Status: WITHDRAWN ·Phase: PHASE3
-
Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence
NCT02032368 ·Status: COMPLETED ·Phase: NA
-
Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer
NCT02862613 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors
NCT06487663 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation
NCT02631499 ·Status: UNKNOWN ·Phase: PHASE4
-
TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial
NCT03636620 ·Status: COMPLETED ·Phase: PHASE3
-
Chemoembolization With or Without Stereotactic Body Radiosurgery for Liver Cancer
NCT02304445 ·Status: WITHDRAWN ·Phase: NA
-
Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion
NCT00826384 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC)
NCT01432314 ·Status: WITHDRAWN ·Phase: PHASE2
-
Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma
NCT00467974 ·Status: COMPLETED ·Phase: PHASE3
-
Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer
NCT02873442 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma
NCT02038296 ·Status: COMPLETED ·Phase: PHASE3
-
Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma
NCT02150317 ·Status: UNKNOWN ·Phase: NA
-
TACE Combined With "Target Immune" Therapy for First-line Treatment in the Treatment of Intrahepatic Cholangiocarcinoma
NCT05247996 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular Carcinoma
NCT05131698 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection
NCT00820053 ·Status: COMPLETED ·Phase: PHASE2
-
TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer
NCT02070419 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effectiveness of Trans-Arterial Chemo Embolization for Hepatocellular Carcinoma on Follow-Up CT Triphasic Liver
NCT07048665 ·Status: ACTIVE_NOT_RECRUITING
-
TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer
NCT02794337 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients
NCT04483284 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Drug-eluting Bead in Hepatocellular Carcinoma
NCT01332669 ·Status: COMPLETED ·Phase: PHASE4
-
Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC
NCT04911959 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2